Your browser doesn't support javascript.
loading
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature.
Stemler, Jannik; Salmanton-García, Jon; Seidel, Danila; Alexander, Barbara D; Bertz, Hartmut; Hoenigl, Martin; Herbrecht, Raoul; Meintker, Lisa; Meißner, Arne; Mellinghoff, Sibylle C; Sal, Ertan; Zarrouk, Marouan; Koehler, Philipp; Cornely, Oliver A.
Afiliación
  • Stemler J; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
  • Salmanton-García J; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Seidel D; German Centre for Infection Research (DZIF), partner site Bonn - Cologne, Cologne, Germany.
  • Alexander BD; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
  • Bertz H; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Hoenigl M; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
  • Herbrecht R; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Meintker L; Infectious Diseases Division, Duke University Medical Center, Durham, NC, USA.
  • Meißner A; Department of Internal Medicine I, Medical Center of Freiburg University, Faculty of Medicine, Freiburg University, Freiburg, Germany.
  • Mellinghoff SC; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
  • Sal E; Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Zarrouk M; Department of Oncology and Hematology, Hôpitaux Universitaires de Strasbourg and Université de Strasbourg, Inserm, UMR-S1113/IRFAC, Strasbourg, France.
  • Koehler P; Department of Medicine 5 for Hematology and Oncology, Erlangen University Hospital, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
  • Cornely OA; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Mycoses ; 63(3): 265-274, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31769549
ABSTRACT

BACKGROUND:

The new Rasamsonia spp. complex can develop invasive infection in immunosuppression or chronic pulmonary disease. It has potential to be misidentified as other genera due to morphological similarities. Nowadays, there is a gap of knowledge on this fungi.

OBJECTIVES:

To provide knowledge base of risk factors and therapeutic decisions in invasive Rasamsonia spp. complex infection. PATIENTS/

METHODS:

Cases of invasive infection due to Rasamsonia spp. (formerly Geosmithia/Penicillium spp.) from FungiScope® registry and all reported cases from a literature were included.

RESULTS:

We identified 23 invasive infections due to Rasamsonia spp., six (26.1%) in the FungiScope® registry. Main risk factors were chronic granulomatous disease (n = 12, 52.2%), immunosuppressive treatment (n = 10, 43.5%), haematopoietic stem cell transplantation (n = 7, 30.4%), graft-versus-host disease and major surgery (n = 4, 17.4%, each). Predominantly affected organs were the lungs (n = 21, 91.3%), disease disseminated in seven cases (30.4%). Fungal misidentification occurred in 47.8% (n = 11), and sequencing was used in 69.6% of the patients (n = 16) to diagnose. Breakthrough infection occurred in 13 patients (56.5%). All patients received antifungal treatment, mostly posaconazole (n = 11), caspofungin (n = 10) or voriconazole (n = 9). Combination therapy was administered in 13 patients (56.5%). Susceptibility testing showed high minimum inhibitory concentrations for azoles and amphotericin B, but not for echinocandins. No preferable treatment influencing favourable outcome was identified. Overall mortality was 39% (n = 9).

CONCLUSION:

Rasamsonia spp. are emerging fungi causing life-threatening infections, especially in immunocompromised and critically ill patients. Mortality is high. Treatment is challenging and clinicians dealing with this patient population should become aware of this infection constituting a medical emergency.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Transmisibles Emergentes / Eurotiales / Infecciones Fúngicas Invasoras / Micosis / Antifúngicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Asia / Europa Idioma: En Revista: Mycoses Asunto de la revista: MICROBIOLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Transmisibles Emergentes / Eurotiales / Infecciones Fúngicas Invasoras / Micosis / Antifúngicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Asia / Europa Idioma: En Revista: Mycoses Asunto de la revista: MICROBIOLOGIA Año: 2020 Tipo del documento: Article